Spruce Biosciences, Inc. Long-Term Debt, Maturity, Year Five
Spruce Biosciences, Inc. (SPRB) had Long-Term Debt, Maturity, Year Five of $135.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2022-11-10
- 2022-09-30: Long-Term Debt, Maturity, Year Five $135.00K.
- 2021-12-31: Long-Term Debt, Maturity, Year Five $135.00K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2022-09-30 | $135.00K 10-Q · filed 2022-11-10 |
| 2021-12-31 | $135.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |